Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Toru Matsugasumi"'
Autor:
Hideya Yamazaki, Koji Masui, Gen Suzuki, Norihiro Aibe, Daisuke Shimizu, Takuya Kimoto, Kei Yamada, Akihisa Ueno, Toru Matsugasumi, Yasuhiro Yamada, Takumi Shiraishi, Atsuko Fujihara, Ken Yoshida, Satoaki Nakamura
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract To compare gastrointestinal (GI) and genitourinary (GU) toxicities in patients with localized prostate cancer treated with ultrahypofractionated radiotherapy (UHF) or brachytherapy [BT; low dose rate, LDR or high dose rate (HDR) with or with
Externí odkaz:
https://doaj.org/article/20f6e27f3a5e48039630a678f5226b70
Autor:
Toru Matsugasumi, Koji Masui, Kaori Yamada, Sho Watanabe, Koji Okihara, Nana Kozawa, Yasuhiro Yamada, Hideya Yamazaki, Kei Yamada, Osamu Ukimura
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 854-860 (2021)
Prostate squamous cell carcinoma (pSCC) rarely develops as a secondary cancer after treatment with low-dose-rate brachytherapy (LDR-BT). There is no established effective treatment for the disease condition. Herein, we present a 78-year-old man who d
Externí odkaz:
https://doaj.org/article/9e1218652e354894b1c7308d57e7462a
Autor:
Takashi Ueda, Takumi Shiraishi, Saya Ito, Munehiro Ohashi, Toru Matsugasumi, Yasuhiro Yamada, Atsuko Fujihara, Fumiya Hongo, Koji Okihara, Osamu Ukimura
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Abstract The objective of this study was to compare the efficacy of abiraterone acetate with that of bicalutamide in combination with gonadotropin-releasing hormone (GnRH) antagonist treatment for patients with high-risk metastatic hormone-sensitive
Externí odkaz:
https://doaj.org/article/b60f435352f8409780bd19222a2b875c
Autor:
Hideya Yamazaki, Koji Masui, Gen Suzuki, Norihiro Aibe, Daisuke Shimizu, Takuya Kimoto, Kei Yamada, Akihisa Ueno, Toru Matsugasumi, Yasuhiro Yamada, Takumi Shiraishi, Atsuko Fujihara, Koji Okihara, Ken Yoshida, Satoaki Nakamura
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract To compare the outcomes of localized prostate cancer treatment with high-dose-rate brachytherapy (HDR-BT) and low-dose-rate brachytherapy (LDR-BT), we examined 924 patients treated with HDR-BT + external beam radiotherapy (EBRT) and 500 pati
Externí odkaz:
https://doaj.org/article/2b6a007a3259409b8e17b0cf33beafed
Remitting seronegative symmetrical synovitis with pitting edema syndrome in maintenance hemodialysis
Autor:
Toru Matsugasumi, Tsuneyuki Nakanouchi, Kazuya Mikami, Takumi Shiraishi, Masatoshi Kadoya, Seijiro Toriyama, Hidefumi Taniguchi, Atsuko Fujihara, Fumiya Hongo, Osamu Ukimura
Publikováno v:
IJU Case Reports, Vol 3, Iss 6, Pp 278-281 (2020)
Introduction The remitting seronegative symmetrical synovitis with pitting edema syndrome primarily occurs in elderly individuals to represent symptoms of edema, pain, and joint swelling. It could be misdiagnosed in elderly maintenance hemodialysis p
Externí odkaz:
https://doaj.org/article/e7b8e1040edc4d3fb8a5c6126e112993
Publikováno v:
IJU Case Reports, Vol 3, Iss 4, Pp 121-124 (2020)
Introduction Secondary bladder, colon, and rectal cancers are relatively common after prostate radiotherapy. However, secondary squamous cell carcinoma of the prostate is rare. Case presentation An 85‐year‐old man presented with dysuria and low
Externí odkaz:
https://doaj.org/article/2a0c03c4318a4547856d7ee3121ef88f
Autor:
Tsukasa Narukawa, Fumiya Hongo, Atsuko Fujihara, Akihisa Ueno, Toru Matsugasumi, Osamu Ukimura
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 1, Pp 249-254 (2020)
Nivolumab, a programmed death-1 checkpoint inhibitor, is worldwide available for metastatic renal cell carcinoma (mRCC). Limited data exist on the response to vascular endothelial growth factor receptor-tyrosine kinase inhibitor (TKI) therapy after a
Externí odkaz:
https://doaj.org/article/2c93b95875e7452880f6a3e433cffeb5
Autor:
Hidehisa Boku, Masatomo Kaneko, Yasuhiro Yamada, Yukiko Morinaga, Eiichi Konishi, Aoi Uno, Toshiko Ito‐Ihara, Ayumu Yamada, Go Horiguchi, Satoshi Teramukai, Atsuko Fujihara, Takumi Shiraishi, Takeshi Yamada, Takashi Ueda, Toru Matsugasumi, Munehiro Ohashi, Daisuke Horiuchi, Yuta Inoue, Osamu Ukimura
Publikováno v:
BJU International. 130:776-785
To examine the safety and efficacy of microwave tissue coagulation (MTC) for prostate cancer and assess its use in lesion-targeted focal therapy in a non-clinical study and a clinical phase II trial.In the non-clinical study using MicrotazeThe region
Autor:
Kaori Yamada, Kei Yamada, Yasuhiro Yamada, Nana Kozawa, Hideya Yamazaki, Sho Watanabe, Toru Matsugasumi, Koji Masui, Koji Okihara, Osamu Ukimura
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 14, Iss 2, Pp 854-860 (2021)
Case Reports in Oncology, Vol 14, Iss 2, Pp 854-860 (2021)
Prostate squamous cell carcinoma (pSCC) rarely develops as a secondary cancer after treatment with low-dose-rate brachytherapy (LDR-BT). There is no established effective treatment for the disease condition. Herein, we present a 78-year-old man who d
Remitting seronegative symmetrical synovitis with pitting edema syndrome in maintenance hemodialysis
Autor:
Kazuya Mikami, Atsuko Fujihara, Toru Matsugasumi, Seijiro Toriyama, Tsuneyuki Nakanouchi, Fumiya Hongo, Osamu Ukimura, Masatoshi Kadoya, Hidefumi Taniguchi, Takumi Shiraishi
Publikováno v:
IJU Case Reports
IJU Case Reports, Vol 3, Iss 6, Pp 278-281 (2020)
IJU Case Reports, Vol 3, Iss 6, Pp 278-281 (2020)
Introduction The remitting seronegative symmetrical synovitis with pitting edema syndrome primarily occurs in elderly individuals to represent symptoms of edema, pain, and joint swelling. It could be misdiagnosed in elderly maintenance hemodialysis p